CANTARGIA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.8 SEK | +11.84% |
|
+35.59% | +28.41% |
| 05-23 | Cantargia Presents New Positive Clinical Data on Nadunolimab Counteracting Chemotherapy Induced Neuropathy | CI |
| 05-21 | Transcript : Cantargia AB, Q1 2024 Earnings Call, May 21, 2024 |
f432eb88e.SMckOITfLK37pG6_fsVlQ3uXKbZnYGdMt2Wt4wmgPWY.A6BmCrGMeO-plkPoCq8IdhfvWdIBIT4Z-TLjvF_HdRAupXVxyrZm7pWcKw~d275b7eda6730d4d79e6dd87e748246c
